Homology Medicines Inc (FIXX)

Homology Medicines (FIXX) Stock Price & Analysis


FIXX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.90 - $3.31
Previous Close$0.91
Average Volume (3M)160.06K
Market Cap
Enterprise Value-$93.06M
Total Cash (Recent Filing)$175.03M
Total Debt (Recent Filing)$29.48M
Price to Earnings (P/E)-9.2
May 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding57,678,435
10 Day Avg. Volume369,912
30 Day Avg. Volume160,056
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)0.29
Price to Sales (P/S)16.36
Price to Cash Flow (P/CF)57.40
P/FCF Ratio3.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-29.01
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.71
Price Target Upside910.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Homology Medicines Inc’s price range in the past 12 months?
Homology Medicines Inc lowest stock price was $0.90 and its highest was $3.31 in the past 12 months.
    What is Homology Medicines Inc’s market cap?
    Currently, no data Available
    When is Homology Medicines Inc’s upcoming earnings report date?
    Homology Medicines Inc’s upcoming earnings report date is May 15, 2023 which is in 49 days.
      How were Homology Medicines Inc’s earnings last quarter?
      Homology Medicines Inc released its earnings results on Mar 09, 2023. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.492 by -$0.108.
        Is Homology Medicines Inc overvalued?
        According to Wall Street analysts Homology Medicines Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Homology Medicines Inc pay dividends?
          Homology Medicines Inc does not currently pay dividends.
          What is Homology Medicines Inc’s EPS estimate?
          Homology Medicines Inc’s EPS estimate is -$0.53.
            How many shares outstanding does Homology Medicines Inc have?
            Homology Medicines Inc has 57,678,436 shares outstanding.
              What happened to Homology Medicines Inc’s price movement after its last earnings report?
              Homology Medicines Inc reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.492. Following the earnings report the stock price went down -8.209%.
                Which hedge fund is a major shareholder of Homology Medicines Inc?
                Among the largest hedge funds holding Homology Medicines Inc’s share is Caxton Associates LP. It holds Homology Medicines Inc’s shares valued at N/A.


                  Homology Medicines Stock Smart Score

                  The Homology Medicines stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Homology Medicines Inc

                  Homology Medicines, Inc. operates as a technology platform to design and develop treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.


                  Top 5 ETFs holding FIXX

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold FIXX. The ETFs are listed according to market value of FIXX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  vTv Therapeutics
                  Viracta Therapeutics
                  MiNK Therapeutics
                  Immune Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis